Search

Your search keyword '"Yang, Ming-Yi"' showing total 126 results

Search Constraints

Start Over You searched for: Author "Yang, Ming-Yi" Remove constraint Author: "Yang, Ming-Yi"
126 results on '"Yang, Ming-Yi"'

Search Results

2. Correlation of distribution characteristics and dynamic changes of gut microbiota with the efficacy of immunotherapy in EGFR-mutated non-small cell lung cancer

3. PD-L1 expression guidance on sintilimab versus pembrolizumab with or without platinum-doublet chemotherapy in untreated patients with advanced non-small cell lung cancer (CTONG1901): A phase 2, randomized, controlled trial

4. Efficacy, safety and dose selection of AZD3759 in patients with untreated EGFR-mutated non-small-cell lung cancer and central nervous system metastases in China (CTONG1702-Arm 8): a multi-center, single-arm, phase 2 trial

7. Redoxhigh phenotype mediated by KEAP1/STK11/SMARCA4/NRF2 mutations diminishes tissue-resident memory CD8+ T cells and attenuates the efficacy of immunotherapy in lung adenocarcinoma.

11. Redox high phenotype mediated by KEAP1/STK11/SMARCA4/NRF2 mutations diminishes tissue-resident memory CD8+ T cells and attenuates the efficacy of immunotherapy in lung adenocarcinoma

12. 3D Covalent Organic Frameworks with 16-Connectivity for Photocatalytic C(sp3)–C(sp2) Cross-Coupling

14. The Distribution Characteristics and Dynamic Changes of Gut Microbiota Indicates the Efficacy of Immunotherapy in Advanced EGFR-Mutated Non-Small Cell Lung Cancer

15. PD-L1 expression guidance on sintilimab versus pembrolizumab with or without platinum-doublet chemotherapy in untreated patients with advanced non-small cell lung cancer (CTONG1901): a phase 2, randomized, controlled trial

18. Immune suppressive microenvironment in liver metastases contributes to organ-specific response of immunotherapy in advanced non-small cell lung cancer

20. Heterogeneity in the immune microenvironment of bone metastasis in driver‐positive non‐small cell lung cancer

22. Efficacy, Safety and Dose Selection of AZD3759 in Patients with Untreated EGFR-Mutated Non-Small-Cell Lung Cancer and Central Nervous System Metastases in a Phase 2, Multi-Center, Umbrella Trial (CTONG1702)

24. Relative Local Electron Density Tuning in Metal‐Covalent Organic Frameworks for Boosting CO2 Photoreduction.

26. Sintilimab versus pembrolizumab in monotherapy or combination with chemotherapy as first-line therapy for advanced non–small cell lung cancer: Results from phase 2, randomized clinical trial (CTONG1901).

29. Partitioning the contributions of sheet and rill erosion using beryllium-7 and cesium-137

34. Covalent Organic Framework Based Functional Materials: Important Catalysts for Efficient CO2 Utilization.

38. Effect of vegetation utilization on runoff and sediment production on grain-for-green slopes in the wind-water erosion crisscross region.

41. Ultrafine Cu nanoclusters confined within covalent organic frameworks for efficient electroreduction of CO2to CH4by synergistic strategy

Catalog

Books, media, physical & digital resources